Tue, January 18, 2011
Mon, January 17, 2011
Fri, January 14, 2011
[ Fri, Jan 14th 2011 ] - Market Wire
ICON Acquires Oxford Outcomes
Thu, January 13, 2011
Wed, January 12, 2011
Tue, January 11, 2011
Mon, January 10, 2011
[ Mon, Jan 10th 2011 ] - Market Wire
Teleflex Acquires VasoNova Inc.
[ Mon, Jan 10th 2011 ] - Market Wire
30 A.M. ET
Sun, January 9, 2011
Fri, January 7, 2011
Thu, January 6, 2011
Wed, January 5, 2011
Tue, January 4, 2011
Mon, January 3, 2011
Fri, December 31, 2010
Thu, December 30, 2010
Wed, December 29, 2010
Tue, December 28, 2010
Mon, December 27, 2010
Fri, December 24, 2010
Thu, December 23, 2010
Wed, December 22, 2010
Tue, December 21, 2010
Mon, December 20, 2010
Fri, December 17, 2010
Thu, December 16, 2010
Wed, December 15, 2010

Law Office of Brodsky & Smith, LLC Announces Investigation of CPEX Pharmaceuticals, Inc.


//health-fitness.news-articles.net/content/2011/ .. s-investigation-of-cpex-pharmaceuticals-inc.html
Published in Health and Fitness on Tuesday, January 4th 2011 at 19:00 GMT by Market Wire   Print publication without navigation


BALA CYNWYD, Pa.--([ BUSINESS WIRE ])--Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of CPEX Pharmaceuticals, Inc. (aCPEXa or the aCompanya) (Nasdaq: CPEX) relating to the proposed acquisition by FCB I Holdings Inc. (aFCBa), a newly formed company which is controlled by Footstar Corporation (aFootstara) in a transaction valued at approximately $76 million.

Under the terms of the offer, CPEX shareholders would receive cash of $27.25 for each share of CPEX stock they own. The investigation concerns possible breaches of fiduciary duty and other violations of state law. The transaction appears to be unfair, in part, given that CPEX stock was trading at its 52 week high, $29.47 a share, as recently as June 2010. Additionally, certain of CPEXa™s directors and employees, who currently own an aggregate of approximately 19.6% of the outstanding CPEX shares, have agreed to vote their shares in favor of the transaction and recommend that all CPEX shareholders approve the transaction.

If you own shares of CPEX and wish to discuss the legal ramifications of the proposed transaction, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at [ investorrelations@brodsky-smith.com ], or by calling toll free 877-LEGAL-90.


Publication Contributing Sources